Dr. James H. Morrissey’s lab at the University of Michigan focuses on understanding the complex mechanisms behind blood clotting, particularly how certain molecules can cause harmful blood clots leading to conditions like heart attacks and strokes. The research aims to differentiate between normal blood clotting processes and those that result in disease, offering insights that could lead to new treatments for thrombotic disorders. Through exploring aspects such as tissue factor interaction and procoagulant polymers, this lab contributes to improving public health outcomes related to clotting disorders.

Dr. Dariya Malyarenko's lab at the University of Michigan focuses on enhancing the accuracy of MRI diffusion imaging in oncology. The team develops correction tools to address biases in diffusion metrics caused by different MRI scanner designs, improving the reliability of cancer diagnosis and treatment assessments. Their work supports multi-center clinical trials, ensuring consistent and precise data across various medical imaging platforms, which is critical for effective cancer management.

Dr. Jacob L. Mueller's lab at the University of Michigan focuses on understanding the competition between genes on sex chromosomes and how these interactions affect fertility. They study the roles of specific gene families that influence sperm success and investigate large palindromic DNA sequences in the genome to uncover their functions and evolutionary significance. By using advanced genetic techniques, the lab aims to provide insights into male infertility and the mechanisms of genetic inheritance.

Dr. Brian D. Ross leads a research lab focused on improving the diagnosis and treatment of myelofibrosis, a serious blood cancer. The lab is developing advanced MRI techniques to create noninvasive biomarkers that can better monitor the disease and evaluate the effectiveness of new targeted therapies. By integrating innovative imaging methods with cutting-edge treatment strategies, they aim to enhance patient management and outcomes for those suffering from this chronic illness.

Dr. Deepak Nagrath's research lab at the University of Michigan investigates how pancreatic cancer interacts with its surrounding environment to influence tumor growth and progression. The lab aims to understand the unique role of stromal cells in supporting cancer metabolism, particularly focusing on branched chain amino acids. By exploring these interactions, they hope to uncover new therapeutic strategies for treating pancreatic cancer.

Dr. Eva Feldman's lab at the University of Michigan focuses on understanding the mechanisms behind neurodegenerative diseases like ALS and the complications of diabetes, particularly peripheral neuropathy. The lab investigates how environmental factors and lifestyle choices impact nerve health and disease progression, aiming to develop targeted prevention and treatment strategies for these debilitating conditions.

Dr. Peter K Todd's lab at the University of Michigan focuses on understanding the genetic causes of Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). The lab investigates how a specific genetic mutation leads to the production of toxic proteins in neurons, potentially revealing new targets for therapeutic intervention. Their research combines cellular models, including patient-derived stem cells, to explore the mechanisms of disease and improve outcomes for affected individuals.

Dr. Nicolai Lehnert's lab at the University of Michigan focuses on developing new materials and methods for generating nitric oxide (NO) gas, which has critical medical uses, including treating lung conditions and preventing infections in medical devices. The lab is specifically working on making low-cost electrochemical systems that can produce NO safely and efficiently, even in the presence of oxygen. By optimizing the catalysts and materials used, the lab aims to enhance NO generation for applications in inhalation therapies and intravascular catheters.

Dr. Akira Ono's lab at the University of Michigan studies the HIV virus and how it infects host cells, particularly CD4+ T cells. They investigate the mechanisms of HIV assembly and entry into these immune cells, focusing on the roles of specific proteins and cellular processes that contribute to the infection cycle. Their research aims to identify new antiviral strategies to combat HIV by interfering with how the virus assembles and spreads within the body.

Dr. Geeta Mehta's lab focuses on understanding the early stages of ovarian cancer, specifically how mutated cells from the fallopian tubes migrate and form tumors. The lab uses innovative microfluidic devices and bioreactors to mimic the fluid environment around these cells, allowing them to study how fluid shear stress affects cell behavior, replication, and potential tumor formation. Their research aims to uncover new insights that could lead to better detection methods and therapies for ovarian cancer.

Dr. Ariella Shikanov's lab focuses on developing innovative therapies to restore ovarian function in young women who suffer premature ovarian insufficiency, often due to cancer treatments. The research aims to enhance the delivery of cell-based therapies using immunoisolating capsules to prevent immune rejection. This work seeks to test the efficacy of these therapies in non-human primate models, paving the way for future clinical applications.

Dr. Stephen Cj Parker's lab focuses on understanding how genetic and environmental factors contribute to diabetes, particularly type 2 diabetes (T2D). They use advanced technologies to study the molecular mechanisms behind insulin resistance, examining various cell types within the pancreas to uncover how genetic variations can impact disease development and tissue organization. The lab aims to create more precise predictions and therapeutic strategies for diabetes by mapping the complex regulatory networks involved.

Dr. Corey A. Lester's lab focuses on improving pharmacy practices by utilizing advanced artificial intelligence (AI) to prevent medication dispensing errors. This research aims to enhance patient safety by designing AI systems that can efficiently catch potential errors in real-time while also assessing the risk involved with different medications. The lab conducts studies to ensure that pharmacy staff can trust these AI technologies, ultimately leading to better decision-making and improved healthcare outcomes.

Dr. Chuan Zhou's research focuses on improving the treatment outcomes for patients with multiple myeloma, a type of blood cancer. His lab is developing a decision support system that combines MRI imaging with clinical data to enhance the prediction of how patients will respond to treatment. By using advanced artificial intelligence methods, the goal is to provide personalized treatment recommendations that can lead to better patient care and outcomes, ultimately working towards precision medicine in oncology.

Dr. Yun Jiang's lab focuses on improving how we detect and characterize prostate cancer using advanced magnetic resonance imaging (MRI) techniques. The lab is developing a rapid and objective method that allows doctors to easily differentiate between clinically significant and less severe forms of prostate cancer. By innovating MRI protocols, this research aims to reduce unnecessary biopsies and improve treatment decisions for patients diagnosed with prostate cancer.

Dr. William E. Rainey’s lab at the University of Michigan focuses on understanding how the adrenal gland produces different hormones. They study the processes that lead to the formation of specific cell types in the adrenal cortex, particularly how progenitor cells develop into hormone-producing cells. The research aims to uncover the molecular mechanisms behind these transformations, which could help in understanding adrenal-related health issues.

Dr. Philip D. King's lab at the University of Michigan focuses on understanding how a specific protein, RASA1, regulates blood vessel development. They study how mutations in this protein can lead to serious vascular malformations in the brain, especially in children. By exploring the molecular mechanisms behind these conditions, the lab aims to find ways to prevent and treat such disorders.

Dr. Nils G. Walter's lab at the University of Michigan focuses on understanding how RNA molecules control gene expression through their unique structures and behaviors. By using advanced microscopy techniques, the lab investigates RNA nanomachines, unraveling their roles in regulating transcription and translation in cells. This research has broad implications for biological processes and can lead to discoveries that reshape our understanding of gene regulation.

Dr. Amanda Garner's lab at the University of Michigan focuses on understanding how RNA-binding proteins interact with RNA molecules in the cell. These interactions are crucial for various biological processes and are involved in diseases like cancer and neurodegeneration. The lab develops new tools to explore these RNA-protein interactions, with the goal of discovering new drug therapies for human health issues.

Dr. Saher Sue Hammoud's lab at the University of Michigan focuses on the critical process of meiosis, which is essential for the production of sperm and eggs. Their research investigates how specific proteins, particularly ZCWPW1, influence the accurate pairing and recombination of chromosomes during this process. By studying these mechanisms, the lab aims to uncover the molecular causes of chromosome mis-segregation, a leading factor in infertility and genetic disorders.